Skip to main content

Viri Sode

NDC 83027-0150 · Nutritional Specialties, Inc.

Generic nameCytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
Dosage formSPRAY
RouteORAL
Active ingredient(s)HUMAN HERPESVIRUS 5, HUMAN HERPESVIRUS 1, HUMAN HERPESVIRUS 2, INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE, RUBELLA VIRUS, HEPATITIS A VIRUS, HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN HERPESVIRUS 4, HUMAN HERPESVIRUS 3
Strength30; 30; 30; 16; 16; 15; 15; 16; 15; 15; 15; 15; 16 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL
Marketing categoryUNAPPROVED HOMEOPATHIC

Packages

83027-0150-1 — 60 mL in 1 BOTTLE, SPRAY (83027-0150-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63083-6017 — Viral Immune Stimulator, 63083-6037 — Visual Detox, 63083-9233 — Mercurius Combination, 63083-9251 — Arsenicum Combination, 63552-722 — influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2)…, 75053-0100 — Gelsemium Sempervirens, Sambucus Nigra, Galphimia Glauca, Causticum, Eupatorium Perfoliatum, Ipecacuanha, Aconitum Napellus, Kali…, 83018-0002 — Lac Vaccinum, Silicea, Aspergillus Niger, Babesia Microti, Borrelia Burgdorferi, Candida Albicans, Candida Parapsilosis, Chlamydia…, 83018-0005 — Lac Vaccinum, Silicea, Aspergillus Niger, Babesia Microti, Borrelia Burgdorferi, Candida Albicans, Candida Parapsilosis, Chlamydia…, 83027-0007 — Dulcamara, Glycyrrhiza Glabra, Ranunculus Bulbosus, Rhus Tox, Natrum Muriaticum, Fagopyrum Esculentum, Natrum Muriaticum, Aconitum…, 83027-0022 — Medulla Ossis Suis, Spleen (Bovine), Thymus (Bovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans,…, 83027-0050 — Asclepias Tuberosa, Echinacea Purpurea, Trifolium Pratense, Natrum Muriaticum, Phytolacca Decandra, Euphrasia Officinalis, Lac Vaccinum…, 83027-0070 — Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B…, 83027-0071 — Thuja Occidentalis, Calcarea Carbonica, Silicea, Salmonella Typhi Nosode, Serum Anguillae, Bacillus Tetani(Clostridium Tetani),…, 83027-0125 — Medulla Ossis Suis, Spleen (Bovine), Thymus (Ovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans,…, 83027-0148 — Medulla Ossis Suis, Spleen (Bovine), Thymus (Ovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2023-2024), Streptococcus Viridans,…, 83027-0153 — Thuja Occidentalis, Calcarea Carbonica, Silicea, Salmonella Typhi Nosode, Serum Anguillae, Bacillus Tetani, Malandrinum, Morbillinum,…, 83027-0156 — Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode,…, 83027-0303 — Dulcamara, Glycyrrhiza Glabra, Ranunculus Bulbosus, Rhus Tox, Natrum Muriaticum, Fagopyrum Esculentum, Natrum Hypochlorous, Aconitum…, 83027-0304 — Cytomegalovirus Nosode, Herpes Simplex I and II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C…, 83703-087 — INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2)…, +92 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels